[go: up one dir, main page]

NO303732B1 - Porfyrinkompleksforbindelser, farmasoytisk middel inneholdende minst ett av disse og anvendelse av minst ett av disse for fremstilling av midler for NMR- eller radiodiagnostikk, samt for radioterapi - Google Patents

Porfyrinkompleksforbindelser, farmasoytisk middel inneholdende minst ett av disse og anvendelse av minst ett av disse for fremstilling av midler for NMR- eller radiodiagnostikk, samt for radioterapi

Info

Publication number
NO303732B1
NO303732B1 NO19951166A NO951166A NO303732B1 NO 303732 B1 NO303732 B1 NO 303732B1 NO 19951166 A NO19951166 A NO 19951166A NO 951166 A NO951166 A NO 951166A NO 303732 B1 NO303732 B1 NO 303732B1
Authority
NO
Norway
Prior art keywords
agents
well
pct
radiotherapy
nmr
Prior art date
Application number
NO19951166A
Other languages
English (en)
Other versions
NO951166L (no
NO951166D0 (no
Inventor
Christoph-Stephan Hilger
Franz Karl Maier
Heinz Gries
Ulrich Niedballa
Johannes Platzek
Mary Lee-Vaupel
Wolfgang Ebert
Juergen Conrad
Josef Gaida
Original Assignee
Inst Fur Diagnostikforschung G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Fur Diagnostikforschung G filed Critical Inst Fur Diagnostikforschung G
Publication of NO951166L publication Critical patent/NO951166L/no
Publication of NO951166D0 publication Critical patent/NO951166D0/no
Publication of NO303732B1 publication Critical patent/NO303732B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19951166A 1992-09-28 1995-03-27 Porfyrinkompleksforbindelser, farmasoytisk middel inneholdende minst ett av disse og anvendelse av minst ett av disse for fremstilling av midler for NMR- eller radiodiagnostikk, samt for radioterapi NO303732B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4232925A DE4232925A1 (de) 1992-09-28 1992-09-28 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
PCT/EP1993/002645 WO1994007894A1 (de) 1992-09-28 1993-09-28 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO951166L NO951166L (no) 1995-03-27
NO951166D0 NO951166D0 (no) 1995-03-27
NO303732B1 true NO303732B1 (no) 1998-08-24

Family

ID=6469326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951166A NO303732B1 (no) 1992-09-28 1995-03-27 Porfyrinkompleksforbindelser, farmasoytisk middel inneholdende minst ett av disse og anvendelse av minst ett av disse for fremstilling av midler for NMR- eller radiodiagnostikk, samt for radioterapi

Country Status (11)

Country Link
US (1) US5849259A (no)
EP (1) EP0662972B1 (no)
JP (1) JPH08504399A (no)
AT (1) ATE226953T1 (no)
CA (1) CA2145509C (no)
DE (2) DE4232925A1 (no)
DK (1) DK0662972T3 (no)
ES (1) ES2186677T3 (no)
NO (1) NO303732B1 (no)
WO (1) WO1994007894A1 (no)
ZA (1) ZA937194B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0758907A1 (en) * 1994-05-11 1997-02-26 Schering Aktiengesellschaft The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis
DE19719033C1 (de) * 1997-04-29 1999-01-28 Schering Ag Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
EP0885616A1 (de) * 1997-06-20 1998-12-23 Schering Aktiengesellschaft Verwendung von intravenösen Kontrastmitteln sowie Vorrichtungen für die Projektionsmammographie
US6194566B1 (en) 1997-12-02 2001-02-27 Schering Aktiengesellschaft Process for the production of metalloporphyrin-metal complex conjugates
DE19845782C1 (de) * 1998-09-22 2000-04-13 Schering Ag Verfahren zur Herstellung von Metallporphyrin-Metallkomplex-Konjugaten
US6136841A (en) * 1998-06-02 2000-10-24 Schering Aktiengesellschaft 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production and their use in photodynamic therapy and MRI diagnosis
DE19825512A1 (de) * 1998-06-02 1999-12-09 Schering Ag 3-,8-subsituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
US6251367B1 (en) 1998-07-24 2001-06-26 Schering Aktiengesellschaft Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction
DE19835082A1 (de) * 1998-07-24 2000-02-03 Schering Ag Paramagnetische 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung für das Nekrose- und Infarkt-MR-Imaging
BR0010700A (pt) * 1999-04-30 2002-02-13 Slil Biomedical Corp Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
ES2269138T3 (es) * 1999-04-30 2007-04-01 Cellgate, Inc. Poliaminas y su uso en terapia.
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
EP1148057A4 (en) * 1999-11-30 2002-05-29 Photochemical Co Ltd PORPHYRIN COMPLEX SUPPORTING A NITROIMIDAZOLE
DE19961533A1 (de) * 1999-12-20 2002-03-28 Steag Micro Tech Gmbh Vorrichtung und Verfahren zum Behandeln von Substraten
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US20030072715A1 (en) * 2000-08-02 2003-04-17 Benjamin Frydman Cyclic polyamine compounds for cancer therapy
EP1337504A4 (en) 2000-11-08 2005-10-05 Cellgate Inc NEW POLYAMINE ANALOGON AMINOIC ACID CONJUGATES FOR USE AS CANCER
WO2002096417A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
AU2002344234B2 (en) * 2001-05-31 2007-11-08 Miravant Pharmaceuticals, Inc. Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
JP5000050B2 (ja) * 2001-08-31 2012-08-15 浩 前田 抗腫瘍剤及びその製造方法
DE10240343A1 (de) * 2002-08-27 2004-03-11 Schering Ag Peroxynitrit-Umlagerungskatalysatoren
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
JP5823988B2 (ja) * 2011-01-31 2015-11-25 国立大学法人宇都宮大学 ポルフィリン型骨格を有する化合物の金属錯体の製造方法
CN102363619A (zh) * 2011-11-18 2012-02-29 中国医学科学院生物医学工程研究所 水溶性原卟啉化合物及制备方法及用途
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CA3044877A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
KR20210095168A (ko) 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485086A (en) * 1983-04-11 1984-11-27 Wong Dennis W Radiolabeled tumor imaging agent and method of preparation
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor

Also Published As

Publication number Publication date
CA2145509A1 (en) 1994-04-14
WO1994007894A1 (de) 1994-04-14
DK0662972T3 (da) 2003-03-03
NO951166L (no) 1995-03-27
JPH08504399A (ja) 1996-05-14
EP0662972B1 (de) 2002-10-30
NO951166D0 (no) 1995-03-27
DE4232925A1 (de) 1994-03-31
ZA937194B (en) 1994-04-21
US5849259A (en) 1998-12-15
ES2186677T3 (es) 2003-05-16
ATE226953T1 (de) 2002-11-15
CA2145509C (en) 2005-04-05
DE59310310D1 (de) 2002-12-05
EP0662972A1 (de) 1995-07-19

Similar Documents

Publication Publication Date Title
NO303732B1 (no) Porfyrinkompleksforbindelser, farmasoytisk middel inneholdende minst ett av disse og anvendelse av minst ett av disse for fremstilling av midler for NMR- eller radiodiagnostikk, samt for radioterapi
Kräutler Thermodynamic trans‐Effects of the Nucleotide Base in the B12 Coenzymes
DE69715888D1 (de) Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel
DK172889D0 (da) Triaza makrocykliske forbindelser og metalkomplekser deraf
PL324342A1 (en) Complex compounds of a cascade polymer, method of obtaining them and pharmaceutic agents containing such compounds
ZA934550B (en) Derivatives in the vitamin D series with modifications in 20-position, process for their production,intermediate products for this process,pharmaceutical prepartions containing these derivatives as well as their use for the production of pharmaceutical agents
DE59408142D1 (de) Chelatbildner vom typ xn 1?s 1?o 1? für radioaktive isotope, deren metallkomplexe und ihre verwendung in diagnostik und therapie
HU9601217D0 (en) Antracyclinone derivatives and their use for treating amyloidosis
ATE188873T1 (de) Tris-platin-komplexe
Metcalfe et al. A facile route to bimetallic ruthenium dipyridophenazine complexes
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
GR3030827T3 (en) Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals
NO952925D0 (no) Derivatiserte DTPA-komplekser, farmasöytiske preparater inneholdende disse, deres anvendelse samt fremgangsmåter for deres fremstilling
NO953868D0 (no) Chelatdannere av typen XN1S1X' for radioaktive isotoper, deres metallkomplekser og deres anvendelse i diagnostikk og terapi
GB9121943D0 (en) Organic compounds,processes for their production and their use
Oszajca et al. Mechanistic studies on the reactions of cyanide with a water-soluble Fe (III) porphyrin and their effect on the binding of NO
DE68922686D1 (de) Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden.
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
ATE144986T1 (de) Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
GR3002857T3 (en) Process for the synthesis of heterocycles from palladocyclic complexes
Harris et al. 1-Methyltetradehydrocorrins
Masciocchi et al. Additions and Corrections-Structural and Spectroscopic Correlations in Cadmium (II) Halide Complexes of 2, 2-Dimethylpropane-1, 3-diamine.
NZ304823A (en) Beta carboline derivatives and medicaments
TW377355B (en) Trinuclear cationic platinum complexes having antitumor activity and pharmaceutical compositions containing them
ES8401033A1 (es) Procedimiento de obtencion de sales motoxicas de las 6-ciclohexil-1-hidroxi-4-metil 2-(1h) piridina.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired